- 期刊
- OpenAccess
Integrative Analysis of Response to Tamoxifen Treatment in ER-Positive Breast Cancer Using GWAS Information and Transcription Profiling
並列摘要
Variable response and resistance to tamoxifen treatment in breast cancer patients remains a major clinical problem. To determine whether genes and biological pathways containing SNPs associated with risk for breast cancer are dysregulated in response to tamoxifen treatment, we performed analysis combining information from 43 genome-wide association studies with gene expression data from 298 ER^+ breast cancer patients treated with tamoxifen and 125 ER^+ controls. We identified 95 genes which distinguished tamoxifen treated patients from controls. Additionally, we identified 54 genes which stratified tamoxifen treated patients into two distinct groups. We identified biological pathways containing SNPs associated with risk for breast cancer, which were dysregulated in response to tamoxifen treatment. Key pathways identified included the apoptosis, P53, NFkB, DNA repair and cell cycle pathways. Combining GWAS with transcription profiling provides a unified approach for associating GWAS findings with response to drug treatment and identification of potential drug targets.
延伸閱讀
- Leen, S., Steven, V. L., Marie, D. A., Valérie, D., Annemie, D. P., Gert, V. D. E., Peter, V. D., Luc, D., Peter, V., & Filip, L. (2014). Study Assessing the Quality of Quantification of Estrogen Receptor Protein Expression by Immunohistochemistry and Gene Expression in Breast Cancer. Pathology Research International, (2014), 53-60. https://doi.org/10.1155/2014/372653
- Esfahlan, R. J., Zarghami, N., Esfahlan, A. J., Mollazadeh, M., Nejati, K., & Nasiri, M. (2011). The Possible Impact of Obesity on Androgen, Progesterone and Estrogen Receptors (ERα and ERβ) Gene Expression in Breast Cancer Patients. Breast Cancer: Basic and Clinical Research, (2011), 227-237. https://doi.org/10.4137/BCBCR.S7707
- He, J., Whelan, S. A., Lu, M., Shen, D., Chung, D. U., Saxton, R. E., Faull, K. F., Whitelegge, J. P., & Chang, H. R. (2011). Proteomic-Based Biosignatures in Breast Cancer Classification and Prediction of Therapeutic Response. International Journal of Proteomics, 2011(), 218-233. https://doi.org/10.1155/2011/896476
- Hicks, C., Kumar, R., Pannuti, A., Backus, K., Brown, A., Monico, J., & Miele, L. (2013). An Integrative Genomics Approach for Associating GWAS Information with Triple-Negative Breast Cancer. Cancer Informatics, (2013), 1-20. https://doi.org/10.4137/CIN.S10413
- 陳怡君（2019）。Optimizing Hormonal Therapy in Premenopausal Estrogen Receptor Positive Breast Cancer: Preclinical Studies and Clinical Trials〔博士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU201901046